Generated by AI
Alcon Inc. is a global eye care company focused on products and technologies that support vision health across surgical and everyday care settings. Alcon Inc. develops, manufactures, and markets a broad portfolio for cataract surgery, vitreoretinal procedures, glaucoma care, refractive surgery, contact lenses, lens care, and other ocular health needs. Its Surgical business provides implantable products, surgical equipment, diagnostics, and consumables used by ophthalmologists in hospitals and specialty clinics. Its Vision Care business includes daily disposable and reusable contact lenses, color-enhancing lenses, and a range of eye health products for dry eye, allergies, glaucoma support, contact lens care, and redness relief. Headquartered in Geneva, Switzerland, Alcon Inc. serves eye care professionals, medical institutions, and consumers in markets worldwide as a leading provider in ophthalmology and vision care.
WebsiteChemin de Blandonnet 8
Geneva, MI, 1214
Switzerland
The latest articles about ALC.
Alcon (SWX:ALC) reported strong Q3 2026 sales performance, underscoring momentum in its core eye care operations. The firm received US FDA approvals for new intraocular lens products intended for use in cataract and vision correction procedures. Management broadened the portfolio with the acquisition of Neurotech Pharmaceuticals, adding drug delivery capabilities in ophthalmology. The Q3 sales update and Neurotech Pharmaceuticals deal matter. However, investors should weigh more than this...
Summary of May 5's posts. Generated by AI.
No summary yet.
No summary yet.
Summary of Aug 19's posts. Generated by AI.
Summary of Nov 12's posts. Generated by AI.
Investors talking about ALC also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.